Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khee Chee Soo

Showing results (171-180 of 207) with videos related to

Pageof 21
Sort By:
Scientific Reports|August 12, 2018
Biological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio in soft tissue sarcomaJason Yongsheng Chan, Zewen Zhang, Winston Chew, et al.
Molecular Cancer Therapeutics|September 3, 2009
AZD6244 (ARRY-142886) enhances the therapeutic efficacy of sorafenib in mouse models of gastric cancerShu Yang, Van Chanh Ngo, Guo Bin Lew, et al.
Cancers|July 9, 2022
Prospective Comparison of the Performance of MRI Versus CT in the Detection and Evaluation of Peritoneal Surface MalignanciesClaramae Shulyn Chia, Louis Choon Kit Wong, Tiffany Priyanthi Hennedige, et al.
Cell Death & Disease|December 24, 2024
Genomic and transcriptomic profiling of radioresistant prostate and head and neck cancers implicate a BAHD1-dependent modification of DNA damage at the heterochromatinChaw Yee Beh, Celestia Pei Xuan Yeo, Boon Hao Hong, et al.
Plos One|March 12, 2014
Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinomaPierce K H Chow, Donald Y H Poon, Maung-Win Khin, et al.
Molecular Cancer Therapeutics|March 1, 2015
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor EverolimusHung Huynh, Huai-Xiang Hao, Stephen L Chan, et al.
BMC Cancer|November 14, 2018
Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPCKevin Lee Min Chua, Eugenia Li Ling Yeo, Waseem Ahamed Shihabudeen, et al.
Journal of Hepatology|May 21, 2008
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinomaHung Huynh, Pierce K H Chow, Nallasivam Palanisamy, et al.
Asia-Pacific Journal of Clinical Oncology|October 21, 2017
Treatment and outcomes of melanoma in Asia: Results from the National Cancer Centre SingaporeYi Lin Teh, Wei Lin Goh, Sze Huey Tan, et al.
BMC Cancer|November 9, 2016
Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trialMihir Gandhi, Su Pin Choo, Choon Hua Thng, et al.
Pageof 21

Showing results (171-180 of 207) with videos related to

Sort By:
Pageof 21
Scientific Reports|August 12, 2018
Biological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio in soft tissue sarcomaJason Yongsheng Chan, Zewen Zhang, Winston Chew, et al.
Molecular Cancer Therapeutics|September 3, 2009
AZD6244 (ARRY-142886) enhances the therapeutic efficacy of sorafenib in mouse models of gastric cancerShu Yang, Van Chanh Ngo, Guo Bin Lew, et al.
Cancers|July 9, 2022
Prospective Comparison of the Performance of MRI Versus CT in the Detection and Evaluation of Peritoneal Surface MalignanciesClaramae Shulyn Chia, Louis Choon Kit Wong, Tiffany Priyanthi Hennedige, et al.
Cell Death & Disease|December 24, 2024
Genomic and transcriptomic profiling of radioresistant prostate and head and neck cancers implicate a BAHD1-dependent modification of DNA damage at the heterochromatinChaw Yee Beh, Celestia Pei Xuan Yeo, Boon Hao Hong, et al.
Plos One|March 12, 2014
Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinomaPierce K H Chow, Donald Y H Poon, Maung-Win Khin, et al.
Molecular Cancer Therapeutics|March 1, 2015
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor EverolimusHung Huynh, Huai-Xiang Hao, Stephen L Chan, et al.
BMC Cancer|November 14, 2018
Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPCKevin Lee Min Chua, Eugenia Li Ling Yeo, Waseem Ahamed Shihabudeen, et al.
Journal of Hepatology|May 21, 2008
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinomaHung Huynh, Pierce K H Chow, Nallasivam Palanisamy, et al.
Asia-Pacific Journal of Clinical Oncology|October 21, 2017
Treatment and outcomes of melanoma in Asia: Results from the National Cancer Centre SingaporeYi Lin Teh, Wei Lin Goh, Sze Huey Tan, et al.
BMC Cancer|November 9, 2016
Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trialMihir Gandhi, Su Pin Choo, Choon Hua Thng, et al.
Pageof 21